NEW YORK, Feb. 17, 2017 /PRNewswire/ -- Sucampo
Pharmaceuticals Inc. (NASD: SCMP) will replace Blue Nile Inc.
(NASD: NILE) in the S&P SmallCap 600 effective at the open of
Thursday, February 23. Blue Nile was
taken private in a transaction completed today.
Sucampo Pharmaceuticals focuses on the research and development
of proprietary drugs for the treatment of gastrointestinal,
ophthalmic, autoimmune, and oncology-based inflammatory disorders.
Headquartered in Rockville, MD,
the company will be added to the S&P SmallCap 600 GICS (Global
Industry Classification Standard) Pharmaceuticals Sub-Industry
index.
Following is a summary of the change:
|
S&P SMALLCAP
600 INDEX – FEBRUARY 23, 2017
|
|
COMPANY
|
GICS ECONOMIC
SECTOR
|
GICS
SUB-INDUSTRY
|
|
ADDED
|
Sucampo
Pharmaceuticals
|
Health
Care
|
Pharmaceuticals
|
|
DELETED
|
Blue Nile
|
Consumer
Discretionary
|
Internet &
Direct
Marketing Retail
|
For more information about S&P Dow Jones Indices, please
visit www.spdji.com
ABOUT S&P DOW JONES INDICES
S&P Dow Jones Indices is the largest global resource for
essential index-based concepts, data and research, and home to
iconic financial market indicators, such as the S&P
500® and the Dow Jones Industrial Average®.
More assets are invested in products based on our indices than
based on any other provider in the world. With over 1,000,000
indices and more than 120 years of experience constructing
innovative and transparent solutions, S&P Dow Jones Indices
defines the way investors measure and trade the markets.
S&P Dow Jones Indices is a division of S&P Global (NYSE:
SPGI), which provides essential intelligence for individuals,
companies, and governments to make decisions with confidence. For
more information, visit www.spdji.com.
FOR MORE INFORMATION:
Soogyung Jordan
Global Head of Communications
New York, USA
(+1) 212 438 2297
soogyung.jordan@spdji.com
David Blitzer
Managing
Director and Chairman of the Index Committee
New York, USA
(+1) 212 438 3907
david.blitzer@spglobal.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sucampo-pharmaceuticals-set-to-join-sp-smallcap-600-300409772.html
SOURCE S&P Dow Jones Indices